Barclays PLC Immunic, Inc. Transaction History

Barclays PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$1.35 - $2.87 $14,347 - $30,502	-10,628 Reduced 13.39%	68,740 $102,000
Q4 2022 Feb 13, 2023	BUY	$1.13 - $10.8 $89,685 - $857,174	79,368 New	79,368 $111,000
Q2 2022 Aug 12, 2022	SELL	$3.13 - $12.25 $8,266 - $32,352	-2,641 Reduced 86.85%	400 $1,000
Q1 2022 May 16, 2022	SELL	$9.54 - $14.26 $187,737 - $280,622	-19,679 Reduced 86.62%	3,041 $35,000
Q4 2021 Feb 14, 2022	BUY	$7.34 - $10.25 $110,591 - $154,436	15,067 Added 196.88%	22,720 $217,000
Q3 2021 Nov 09, 2021	BUY	$8.05 - $13.29 $45,635 - $75,341	5,669 Added 285.74%	7,653 $68,000
Q2 2021 Aug 13, 2021	SELL	$11.76 - $16.85 $31,916 - $45,730	-2,714 Reduced 57.77%	1,984 $24,000
Q1 2021 May 13, 2021	BUY	$14.21 - $25.3 $66,744 - $118,834	4,697 Added 469700.0%	4,698 $75,000
Q4 2020 Feb 11, 2021	SELL	$14.8 - $20.37 $39,101 - $53,817	-2,642 Reduced 99.96%	1 $0
Q3 2020 Nov 12, 2020	BUY	$11.74 - $22.0 $8,640 - $16,192	736 Added 38.59%	2,643 $50,000
Q2 2020 Aug 12, 2020	BUY	$5.67 - $15.86 $10,807 - $30,229	1,906 Added 190600.0%	1,907 $23,000
Q4 2019 Feb 10, 2020	SELL	$6.4 - $10.23 $6 - $10	-1 Reduced 50.0%	1 $0
Q3 2019 Nov 14, 2019	SELL	$10.0 - $17.01 $1,050 - $1,786	-105 Reduced 98.13%	2 $0
Q2 2019 Aug 14, 2019	BUY	$7.88 - $33.2 $843 - $3,552	107 New	107 $1,000

56.1M

4.7K

311K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $50.4M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.